BETADERM Drug Patent Profile
Which patents cover Betaderm, and what generic alternatives are available?
Betaderm is a drug marketed by Roaco and is included in one NDA.
The generic ingredient in BETADERM is betamethasone valerate. There is one drug master file entry for this compound. Twelve suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Betaderm
A generic version of BETADERM was approved as betamethasone valerate by FOUGERA on August 31st, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for BETADERM?
- What are the global sales for BETADERM?
- What is Average Wholesale Price for BETADERM?
Summary for BETADERM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 60 |
| Patent Applications: | 4,697 |
| DailyMed Link: | BETADERM at DailyMed |
US Patents and Regulatory Information for BETADERM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Roaco | BETADERM | betamethasone valerate | CREAM;TOPICAL | 018839-001 | Jun 30, 1983 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
